上海招聘

Responsibilities:

- Excel at understanding of data of brand or competitors, HCP perception, literature and research update in relevant therapeutic areas;

- Generate insights from above resources, then process, integrate and share with cross-functional team;

- Responsible for exhaustive collection of information regarding existing knowledge gap, scientific data gap and clinical care gap;

- Establish Medical Strategy for pre-launch brand and pipeline products;

- Provide strategic advice and support for coporate business development;

- Set up and carry out Medical Plan based on Medical Strategy;

- Conduct productive engagement with key national stakeholders independantly or with cross-functional teams;

- Design and compose study protocol post launch, manage study budget and phasing, submit protocol for internal review and present at investigator meeting if necessary;

- Set plan for CSR and publication, review study report, carry out medical monitoring during clinical study;

- Design and implement medical activities including advisory board, medical symposium, scientific communication meetings, etc.;

- Ensure brand listing in guidelines and consensus with proper positioning;

- Develop medical education slide decks and other material in related TA;

- Responsible for provision of thoughtful input into review of promotional or educational material that is disseminated to or presented by company to external audiences;

- Design and execute patient education and support projects;

- Work closely with cross functions to achieve business goal;

- Provide brand and TA related support to Marketing/Sales team and other departments.

Professional experience & Key projects example:

- Master degree or above in clinical medicine/Biology/Other related major

- 3 years medical working experience on relevant therapeutic area, in which Hematology background is preferred;

- Experience of clinical trial design and implementation;

- Strong communication skills with internal and external stakeholders;

- Team spirit with cross funtions.

德琪医药有限公司（简称“德琪医药”，香港联交所股票代码：6996. HK）是一家专注于创新抗肿瘤药物的亚太地区临床阶段生物制药公司，德琪医药旨在为亚太地区及全球各地的患者提供全新作用机制的抗肿瘤创新疗法。自成立以来，德琪医药已建立起拥有12款临床及临床前创新药物的丰富产品管线，取得9个临床批件，并在亚太地区开展9项跨区域临床试验。公司在研产品专注于创新的靶点或作用机制，并拥有成为同类首款潜力的药物。德琪人以“医者无疆，创新永续”为愿景，力争通过对全球***和同类最优的专研与市场化，解决亚太乃至全球患者未满足的临床需求。